Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Manjunath S. Shet is active.

Publication


Featured researches published by Manjunath S. Shet.


Methods in Enzymology | 1996

APPLICATION OF ELECTROCHEMISTRY FOR P450-CATALYZED REACTIONS

Ronald W. Estabrook; Kevin M. Faulkner; Manjunath S. Shet; Charles W. Fisher

Publisher Summary The heme proteins called P450 catalyze the metabolism of variety of different chemicals. Many of these are oxidation reactions where P450s function as mixed function oxidases. The oxygen chemistry associated with these reactions permits the introduction of an atom of molecular oxygen in a regio- and stereo-specific manner. P450s are excellent candidates as catalysts for the synthesis of high-value speciality chemicals that are difficult to synthesize by conventional chemical oxidation techniques. In addition to molecular oxygen and the chemical substrate to be metabolized, P450s require a source of electrons (NADPH) and an electron transport protein(s) for the transfer of two electrons (in sequence) from NADPH to the hemeprotein. The use of NADPH as a source of electrons serves as an economic limitation for designing reaction systems that require large-scale incubations and may operate for extended time periods. Electrochemical method for a number of P450-catalyzed reactions is used. The results summarized in the chapter show the applicability of the method for a variety of reactions catalyzed by different P450s. The use of bulk electrolysis to drive a P450-catalyzed reaction, in place of NADPH, permits the construction of reactor systems using P450s as catalysts.


Methods in Enzymology | 1996

[2] Construction of plasmids and expression in Escherichia coli of enzymatically active fusion proteins containing the heme-domain of a P450 linked to NADPH-P450 reductase

Charles W. Fisher; Manjunath S. Shet; Ronald W. Estabrook

Publisher Summary This chapter discusses the construction of plasmids and expression in Escherichia coli of enzymatically active fusion proteins containing the heme-domain of a P450 linked to NADPH-P450 reductase. The chapter also describes the design of constructs. An important consideration in the creation of any construct by mutagenesis is to minimize the region of DNA that is subjected to mutagenesis and to confirm by sequencing that only the desired mutations have been introduced into this mutagenized region. The use of (low error rate) thermostable DNA polymerases with proofreading activities has been heralded for use in mutagenesis. The chapter discusses development of P450 catalysts that might be of commercial value for chemical synthetic processes. Therefore, it was important to engineer and express fusion proteins that might be immobilized to a matrix permitting the regenerative flow through of reactant chemicals. In addition, it was important to include additional domains in the fusion protein that might influence a P450 reaction, for example the domain for cytochrome b 5 or the presence of a second flavoprotein-domain.


Endocrine Research | 1996

The use of electrochemistry for the synthesis of 17α-hydroxyprogesterone by a fusion protein containing P450c17

Ronald W. Estabrook; Manjunath S. Shet; Kevin M. Faulkner; Charles W. Fisher

A method has been developed for the commercial application of the unique oxygen chemistry catalyzed by various cytochrome P450s. This is illustrated here for the synthesis of hydroxylated steroids. This method requires the preparation of large amounts of enzymatically functional P450 proteins that can serve as catalysts and a technique for providing electrons at an economically acceptable cost. To generate large amounts of enzymatically active recombinant P450s we have engineered the cDNAs for various P450s, including bovine adrenal P450c17, by linking them to a modified cDNA for rat NADPH-P450 reductase and placing them in the plasmid pCWori+. Transformation of E. coli results in the high level expression of an enzymatically active protein that can be easily purified by affinity chromatography. Incubation of the purified enzyme with steroid in a reaction vessel containing a platinum electrode and a Ag/AgCl electrode couple poised at -650 mV, together with the electromotively active redox mediator, cobalt sepulchrate, results in the 17 alpha-hydroxylation of progesterone at rates as high as 25 nmoles of progesterone hydroxylated/min/nmole of P450. Thus, high concentrations of hydroxylated steroids can be produced with incubation conditions of hours duration without the use of costly NADPH. Similar experiments have been carried out for the generation of the 6 beta-hydroxylation product of testosterone (using a fusion protein containing human P450 3A4). It is apparent that this method is applicable to many other P450 catalyzed reactions for the synthesis of large amounts of hydroxylated steroid metabolites. The electrochemical system is also applicable to drug discovery studies for the characterization of drug metabolites.


Proceedings of the National Academy of Sciences of the United States of America | 1993

Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase.

Manjunath S. Shet; Charles W. Fisher; Priscilla L. Holmans; Ronald W. Estabrook


Proceedings of the National Academy of Sciences of the United States of America | 1992

High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein

Charles W. Fisher; Manjunath S. Shet; D L Caudle; C A Martin-Wixtrom; Ronald W. Estabrook


Drug Metabolism and Disposition | 1997

METABOLISM OF THE ANTIANDROGENIC DRUG (FLUTAMIDE) BY HUMAN CYP1A2

Manjunath S. Shet; Michael J. McPhaul; Charles W. Fisher; Nancy R. Stallings; Ronald W. Estabrook


Proceedings of the National Academy of Sciences of the United States of America | 1995

Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.

K M Faulkner; Manjunath S. Shet; Charles W. Fisher; Ronald W. Estabrook


Archives of Biochemistry and Biophysics | 1996

THE INTERACTION OF NADPH-P450 REDUCTASE WITH P450 : AN ELECTROCHEMICAL STUDY OF THE ROLE OF THE FLAVIN MONONUCLEOTIDE-BINDING DOMAIN

Ronald W. Estabrook; Manjunath S. Shet; Charles W. Fisher; Christopher M. Jenkins; Michael R. Waterman


Archives of Biochemistry and Biophysics | 1997

The Function of Recombinant Cytochrome P450s in IntactEscherichia coliCells: The 17α-Hydroxylation of Progesterone and Pregnenolone by P450c17☆☆☆

Manjunath S. Shet; Charles W. Fisher; Ronald W. Estabrook


Archives of Biochemistry and Biophysics | 1996

The Omega-Hydroxylation of Lauric Acid: Oxidation of 12-Hydroxylauric Acid to Dodecanedioic Acid by a Purified Recombinant Fusion Protein Containing P450 4A1 and NADPH–P450 Reductase

Manjunath S. Shet; Charles W. Fisher; Priscila L. Holmans; Ronald W. Estabrook

Collaboration


Dive into the Manjunath S. Shet's collaboration.

Top Co-Authors

Avatar

Charles W. Fisher

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ronald W. Estabrook

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kevin M. Faulkner

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ajay Madan

Neurocrine Biosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher M. Jenkins

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nancy R. Stallings

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Priscila L. Holmans

University of Texas Southwestern Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge